当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析 - 利润表

亿帆医药

(002019)

  

流通市值:142.82亿  总市值:207.33亿
流通股本:8.50亿   总股本:12.34亿

利润表

按照会计年度查询:
报告期2021-09-302021-06-302021-03-312020-12-31
一、营业总收入3,397,522,083.072,377,403,852.31,200,337,373.235,400,380,581.37
营业收入3,397,522,083.072,377,403,852.31,200,337,373.235,400,380,581.37
二、营业总成本3,124,960,572.22,158,408,907.921,065,298,825.324,436,702,418.77
营业成本2,020,847,282.251,426,112,230.79721,608,037.12,890,465,561.01
营业税金及附加25,342,770.1417,147,317.636,863,141.5642,112,683.62
销售费用607,223,802.44401,725,616.45194,565,658.02703,368,503.09
管理费用299,217,686.3195,982,542.9197,302,137.52408,090,879.64
财务费用39,370,385.1423,393,141.74,446,482.4867,323,863.85
资产减值损失-3,227,332.18-2,212,059.69-183,353.87-10,369,735.86
三、其他经营收益-38,092,525.25-23,118,872.97-3,690,687.89-71,899,929.29
允许价值变动净收益149,138.26302,197.52-257,707.74-14,482.73
投资净收益-8,652,029.04-6,107,349.22-6,777,267.486,947,475.82
联营、合营企业投资收益-13,031,115.07-9,929,301.42-7,894,946.34110,458.2
汇兑净收益--------
四、营业利润277,135,721.74214,495,116.57134,304,706.571,084,556,151.71
营业外收入19,047,744.8718,662,512.6714,879,379.44,670,391.38
营业外支出3,325,413.762,362,609.211,614,746.778,513,935.14
非流动资产处置净损失--------
五、利润总额292,858,052.85230,795,020.03147,569,339.21,080,712,607.95
所得税50,524,236.6748,948,058.0729,347,507.86149,318,621.39
未确认的投资损失--------
六、净利润(百万元)290.76213.14132.24968.39
少数股东损益-48,429,622.53-31,294,127.58-14,023,010.76-36,996,576.99
归属于母公司股东的净利润290,763,438.71213,141,089.54132,244,842.1968,390,563.55
七、每股收益--0.170.110.8
基本每股收益0.240.170.110.8
稀释每股收益0.240.170.110.79
TOP↑